Literature DB >> 26550049

The Utility of Segmental Analysis in Cardiac I-123 MIBG SPECT in Parkinson's Disease.

Soo Hyun Kwon1, Joon-Kee Yoon1, Jung Han Yoon2, Su Jin Lee1, Kyung Sook Jo1, Dong Hyun Lee1, Young-Sil An1.   

Abstract

PURPOSE: Cardiac images using I-123 metaiodobenzylguanidine (MIBG) are widely used to evaluate cardiac sympathetic denervation in Parkinson's disease (PD). The aim of this study was to evaluate the utility of segmental analysis on cardiac MIBG SPECT in PD patients.
MATERIALS AND METHODS: In total, 36 patients with PD (n = 26) or essential tremor (ET, n = 10) who underwent MIBG cardiac SPECT were enrolled. The heart-to-mediastinum (H/M) ratios of MIBG uptake were acquired on planar images. For the segmental analysis of SPECT images, we evaluated the summed defect score (SDS) using a 17-segment model. The diagnostic abilities of H/M ratios and segmental parameters on MIBG SPECT were assessed by ROC curve analysis.
RESULTS: The H/M ratios were significantly lower in PD than in ET patients (p < 0.05). On segmental analysis, SDS was significantly higher in PD patients than in the ET group (7.04 ± 4.09 vs. 2.90 ± 2.80; p = 0.006). The defect score of the anteroseptal region showed a significant difference between the groups (p = 0.002). The ROC analysis suggested only SDS (AUC = 0.785, p = 0.0003) and defect scores in the anteroseptal (AUC = 0.800, p < 0.0001) and inferior (AUC = 0.667, p = 0.013) regions showed significant diagnostic ability to differentiate PD from ET.
CONCLUSIONS: Segmental parameters from cardiac MIBG SPECT images can provide additional information to differentiate PD from ET patients. Beyond H/M ratios from planar images, we recommend an MIBG SPECT study to evaluate sympathetic denervation in PD.

Entities:  

Keywords:  Heart; I-123 MIBG; Parkinson’s disease; SPECT; Segmental analysis

Year:  2015        PMID: 26550049      PMCID: PMC4630334          DOI: 10.1007/s13139-015-0354-0

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  13 in total

1.  Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.

Authors:  Joong-Seok Kim; Phil-Hyu Lee; Kwang-Soo Lee; Jeong-Wook Park; Yeong-In Kim; Yong-An Chung; Sung-Hoon Kim; Seung-Hyun Kim; Juhan Kim; Yun-Young Choi; Hee-Tae Kim
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

2.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Cardiac 123I-MIBG scintigraphy in patients with essential tremor.

Authors:  Phil Hyu Lee; Ji Won Kim; Oh Young Bang; In Soo Joo; Seok-Nam Yoon; Kyoon Huh
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

4.  Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age.

Authors:  M Estorch; I Carrió; L Berná; J López-Pousa; G Torres
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

Review 5.  Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.

Authors:  Junichi Taki; Mitsuhiro Yoshita; Masahito Yamada; Norihisa Tonami
Journal:  Ann Nucl Med       Date:  2004-09       Impact factor: 2.668

Review 6.  Cardiac sympathetic imaging with mIBG in heart failure.

Authors:  Ignasi Carrió; Martin R Cowie; Junichi Yamazaki; James Udelson; Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

7.  Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.

Authors:  P H Lee; J S Kim; D H Shin; S-N Yoon; K Huh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

Review 8.  Neurological applications for myocardial MIBG scintigraphy.

Authors:  Cascini Giuseppe Lucio; Cuccurullo Vincenzo; Restuccia Antonio; Tamburrini Oscar; Rotondo Antonio; Mansi Luigi
Journal:  Nucl Med Rev Cent East Eur       Date:  2013

9.  Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Authors:  Frédéric Courbon; Christine Brefel-Courbon; Claire Thalamas; Marie-Jeanne Alibelli; Isabelle Berry; Jean-Louis Montastruc; Olivier Rascol; Jean-Michel Senard
Journal:  Mov Disord       Date:  2003-08       Impact factor: 10.338

10.  Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies.

Authors:  G Aernout Somsen; Hein J Verberne; Eric Fleury; Alberto Righetti
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

View more
  4 in total

Review 1.  The Current Status of SPECT or SPECT/CT in South Korea.

Authors:  Ikdong Yoo; Eun Kyoung Choi; Yong-An Chung
Journal:  Nucl Med Mol Imaging       Date:  2016-04-22

Review 2.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

Review 3.  Imaging Systemic Dysfunction in Parkinson's Disease.

Authors:  Per Borghammer; Karoline Knudsen; David J Brooks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

4.  Imaging Parkinson's disease below the neck.

Authors:  Per Borghammer; Karoline Knudsen; Tatyana D Fedorova; David J Brooks
Journal:  NPJ Parkinsons Dis       Date:  2017-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.